Xencor | XNCR - Interest Expense On Debt


Xencor reported $7.35M in Interest Expense on Debt for its fiscal quarter ending in June of 2026.





Interest Expense On Debt Change Date
AbbVie USD 645M 69M Mar/2026
Alnylam Pharmaceuticals USD 82.05M 12.76M Jun/2026
Amgen USD 95.64B 94.98B Jun/2026
Arrowhead Research USD 24.56M 716K Jun/2026
AstraZeneca USD 340M 144M Jun/2026
Biogen USD 72.6M 12.6M Jun/2025
Bristol-Myers Squibb USD 407M 4M Jun/2026
Cytokinetics USD 34.83M 1.5M Jun/2026
GlaxoSmithKline GBP 121M 46M Jun/2026
J&J USD 43M 25M Mar/2026
Karyopharm Therapeutics USD 12.55M 66K Mar/2026
MacroGenics USD 4.89M 1.55M Mar/2026
Merck USD 525M 46M Jun/2026
Novartis USD 462M 119M Jun/2026
Pfizer USD 667M 4M Jun/2026
Regeneron Pharmaceuticals USD 11M 1.9M Jun/2026
Roche Holding CHF 304M 7.5M Jun/2025
Xencor USD 7.35M 2.65M Jun/2026